Edge Wealth Management LLC Has $37,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Edge Wealth Management LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 40.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 94 shares of the healthcare conglomerate’s stock after buying an additional 27 shares during the quarter. Edge Wealth Management LLC’s holdings in UnitedHealth Group were worth $37,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the company. FMR LLC grew its holdings in shares of UnitedHealth Group by 0.6% during the second quarter. FMR LLC now owns 50,452,463 shares of the healthcare conglomerate’s stock valued at $20,203,185,000 after buying an additional 291,660 shares during the last quarter. State Street Corp grew its holdings in shares of UnitedHealth Group by 1.9% during the second quarter. State Street Corp now owns 44,530,535 shares of the healthcare conglomerate’s stock valued at $17,831,807,000 after buying an additional 838,941 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of UnitedHealth Group by 4.7% during the second quarter. Geode Capital Management LLC now owns 15,110,522 shares of the healthcare conglomerate’s stock valued at $6,033,290,000 after buying an additional 679,484 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in shares of UnitedHealth Group by 3.8% during the second quarter. Bank of New York Mellon Corp now owns 9,579,497 shares of the healthcare conglomerate’s stock valued at $3,836,011,000 after buying an additional 354,695 shares during the last quarter. Finally, Morgan Stanley lifted its position in shares of UnitedHealth Group by 9.7% during the second quarter. Morgan Stanley now owns 8,693,237 shares of the healthcare conglomerate’s stock valued at $3,481,120,000 after purchasing an additional 768,188 shares in the last quarter. Hedge funds and other institutional investors own 86.20% of the company’s stock.

In other news, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction that occurred on Friday, September 17th. The shares were sold at an average price of $419.00, for a total value of $1,047,500.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Stephen J. Hemsley sold 75,000 shares of the company’s stock in a transaction on Monday, October 25th. The shares were sold at an average price of $448.72, for a total transaction of $33,654,000.00. The disclosure for this sale can be found here. In the last three months, insiders sold 80,000 shares of company stock valued at $35,743,375. Corporate insiders own 0.55% of the company’s stock.

NYSE:UNH traded up $4.58 during mid-day trading on Tuesday, hitting $442.12. 38,440 shares of the stock traded hands, compared to its average volume of 2,943,648. The business’s 50-day moving average price is $429.12 and its 200 day moving average price is $417.57. The company has a market cap of $416.41 billion, a PE ratio of 27.14, a price-to-earnings-growth ratio of 1.75 and a beta of 0.85. UnitedHealth Group Incorporated has a 12-month low of $320.35 and a 12-month high of $466.00. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.59.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, October 14th. The healthcare conglomerate reported $4.52 EPS for the quarter, topping the Zacks’ consensus estimate of $4.41 by $0.11. UnitedHealth Group had a net margin of 5.52% and a return on equity of 23.08%. The business had revenue of $72.34 billion during the quarter, compared to analysts’ expectations of $71.24 billion. During the same quarter in the previous year, the company earned $3.51 EPS. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group Incorporated will post 18.84 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 14th. Shareholders of record on Monday, December 6th will be paid a $1.45 dividend. The ex-dividend date of this dividend is Friday, December 3rd. This represents a $5.80 dividend on an annualized basis and a yield of 1.31%. UnitedHealth Group’s dividend payout ratio is presently 35.98%.

A number of research firms recently weighed in on UNH. Cowen started coverage on shares of UnitedHealth Group in a research report on Thursday, September 9th. They set an “outperform” rating and a $478.00 price target on the stock. Royal Bank of Canada lifted their price objective on shares of UnitedHealth Group from $473.00 to $476.00 and gave the stock an “outperform” rating in a research report on Friday, October 15th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $477.00 price objective on the stock in a research report on Wednesday, October 27th. SVB Leerink started coverage on shares of UnitedHealth Group in a research report on Monday, September 27th. They issued an “outperform” rating and a $480.00 price objective on the stock. Finally, Morgan Stanley lifted their target price on shares of UnitedHealth Group from $488.00 to $499.00 and gave the stock an “overweight” rating in a research note on Friday, October 15th. One equities research analyst has rated the stock with a hold rating, twenty-one have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $477.35.

About UnitedHealth Group

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

See Also: Google Finance Portfolio

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.